SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-01-502506
Filing Date
2001-11-07
Accepted
2001-11-07 00:00:00
Documents
2
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q j2008_10q.htm 10-Q 405141
3 J200810QIMAGE002.JPG j200810qimage002.jpg GRAPHIC 7620
  Complete submission text file 0001104659-01-502506.txt   414003
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 1777510
SIC: 2835 In Vitro & In Vivo Diagnostic Substances